Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • Intracellular Ca 2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin

    American Journal of Physiology-Cell Physiology Date published:

  • Cell Surface Glypicans Are Low-Affinity Endostatin Receptors

    Molecular Cell Date published:

  • Intracellular Ca2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin

    American Journal of Physiology-Cell Physiology Date published:

  • Central nervous system complications in renal transplant recipients in a tropical environment

    Journal of the Neurological Sciences Date published:

  • Impact of cyclosporine withdrawal on living related renal transplants: A single-center experience

    American Journal of Kidney Diseases Date published:

  • Is “Chinese herbs nephropathy” a prejudical term?

    American Journal of Kidney Diseases Date published:

  • Is" Chinese herbs nephropathy" a prejudicial term?

    American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation Date published:

  • Multiple Myeloma: A rare malignancy in the post transplant period

    Indian Journal of Nephrology Date published:

  • Randomized controlled trial of steroids and cyclophosphamide in adults with idiopathic membranous nephropathy

    J Am Soc Nephrol Date published:

  • The Approach to Dialysis in Developing Countries

    Complications of Dialysis Date published:

  • High-resolution CT in renal transplant patients with suspected pulmonary infections

    Acta Radiologica Date published:

  • Treatment-related acute renal failure in the elderly: a hospital-based prospective study

    Nephrology Dialysis Transplantation Date published:

  • Isoniazid does not affect bioavailability of cyclosporine in renaltransplant recipients

    Methods and Findings in Experimental and Clinical Pharmacology Date published:

  • Isoniazid does not affect bioavailability of cyclosporine in renal transplant recipients.

    Methods and Findings in Experimental and Clinical Pharmacology Date published:

  • Infections in dialysis and transplant patients in tropical countries

    Kidney International Date published:

  • Problems and outcomes of living unrelated donor transplants in the developing countries

    Kidney International Date published: